title: [Long term survival in an HIV-immunosuppressed patient treated with foscarnet].
abstract: An HIV-infected woman with a CD4+ T-cell count below 100 x 10(6)/l survived for longer than 4 years of being diagnosed of AIDS, with acceptable health status (Karnofsky > 80%). Administration of foscarnet during two years, recommended as suppressive therapy for a previous cytomegalovirus retinitis, might have caused a sustained reduction in plasma HIV-RNA, contributing to her long-term survival.
authors.affiliation: Servicio de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid.
authors.forename: V
authors.initials: V
authors.lastname: Soriano
authors.forename: A
authors.initials: A
authors.lastname: Mas
authors.forename: R
authors.initials: R
authors.lastname: Bravo
authors.forename: V
authors.initials: V
authors.lastname: Moreno
authors.forename: J
authors.initials: J
authors.lastname: González-Lahoz
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D005260:Female; D017245:Foscarnet / Q000627:therapeutic use*; D006678:HIV / Q000302:isolation & purification; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
chemical_list: D000998:Antiviral Agents; D012367:RNA, Viral; D017245:Foscarnet